| Evolution of the average Target Price on HELMERICH & PAYNE, INC. |
|
|
|
| Target Price consensus revisions : last 18 months |
|
|
|
| Recommendations (Chart) HELMERICH & PAYNE, INC. |
|
|
|
| Analyst Recommendations on HELMERICH & PAYNE, INC. |
|
| 05/02 | Morgan Stanley Adjusts Helmerich & Payne's Price Target to $50 from $40, Keeps Underweight.. | MT |
| 05/02 | Barclays Adjusts Helmerich & Payne's Price Target to $52 from $33, Keeps Equalweight Ratin.. | MT |
| 04/29 | RBC Capital Adjusts Helmerich & Payne's Price Target to $62 From $56, Maintains Outperform.. | MT |
| 04/14 | Goldman Sachs Adjusts Helmerich & Payne's Price Target to $41 from $36.50, Keeps Sell Rati.. | MT |
| 04/13 | Piper Sandler Adjusts Helmerich & Payne's Price Target to $44 from $32, Keeps Neutral Rati.. | MT |
| 04/12 | ANALYST RECOMMENDATIONS : AstraZeneca, Blackrock, Nasdaq, Rolls-Royce, Warner Bros Discovery... | |
| 04/11 | Benchmark Initiates Helmerich & Payne With Buy Rating, $53 Price Target | MT |
| |
|
|
|
|
| Mean consensus |
OUTPERFORM |
| Number of Analysts |
21 |
| Last Close Price |
45,13 $ |
| Average target price |
48,84 $ |
| Spread / Average Target |
8,23% |
| High Price Target |
62,00 $ |
| Spread / Highest target |
37,4% |
| Low Price Target |
31,00 $ |
| Spread / Lowest Target |
-31,3% |
Consensus revision (last 18 months)
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
